North America

GSI Pharmaceuticals has been a key supplier to the North American pharmaceutical market since its incorporation in 1998. Over the past 19 years, GSI Pharmaceuticals has evolved into a fully integrated supplier of both products and services to both the Generic and Brand Pharmaceutical companies.

We are a large volume supplier of Active Pharmaceutical Ingredients (API’s) manufactured in our global network of partner manufacturing plants. All of these facilities are FDA inspected, cGMP compliant. To complement this core activity, we have established a Generic Pharma Division to work closely with our customers and partners to bring approved ANDA’s to market.

All of our activity is supported by a long term, knowledgeable sales and customer service team and in-depth internal Regulatory department.

GSI Pharmaceuticals was the API supplier in the first Paragraph IV challenge and continues to be very active in many Paragraph IV ANDA filings today. 

GSI Pharmaceuticals has helped biotech industries by investing in new process molecules.  Our successes lead to the launch of a new product in Japan in 2009 with an expected launch in the USA in 2010.

Having anticipated legislative changes, we have been pioneers in taking advantage of the changes in the America's. As a result, GSI Pharmaceuticals has been very active, adapting to the ever changing market place to best service both our suppliers and customers.

GSI Pharmaceuticals is long time members and very active of key North American industry associations such as DCAT, GPhA and CGPA. GSI Pharmaceuticals holds a board member seat on DCAT and GPhA, as well as founding members of organizations such as and GPhA, CPhI, and CGPA.

From Molecule to Market is what we do! Working closely with our suppliers and customers is how we do it! Our team based in North America is looking forward to working with you in establishing an enduring and mutually beneficial relationship.

Need more information? contact us today!